Astrocytoma classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Classification== | ==Classification== | ||
Astrocytoma may be classified according to presence of [[atypia]], [[mitosis]], endothelial proliferation, and [[necrosis]] into four sybgroups. | Astrocytoma may be classified according to presence of [[atypia]], [[mitosis]], endothelial proliferation, and [[necrosis]] into four sybgroups. | ||
* '''Grade 1''' — [[pilocytic astrocytoma]] | * '''Grade 1''' — [[pilocytic astrocytoma]] | ||
* '''Grade 2''' — [[diffuse astrocytoma]] | * '''Grade 2''' — [[diffuse astrocytoma]] | ||
Revision as of 20:25, 27 December 2018
|
Astrocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Study |
|
Astrocytoma classification On the Web |
|
American Roentgen Ray Society Images of Astrocytoma classification |
|
Risk calculators and risk factors for Astrocytoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Astrocytoma may be classified according to its histology into 4 grades: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma and glioblastoma multiforme.
Classification
Astrocytoma may be classified according to presence of atypia, mitosis, endothelial proliferation, and necrosis into four sybgroups.
- Grade 1 — pilocytic astrocytoma
- Grade 2 — diffuse astrocytoma
- Grade 3 — anaplastic astrocytoma
- Grade 4 — glioblastoma multiforme
- The WHO-grading scheme is based on the appearance of certain characteristics: atypia, mitosis, endothelial proliferation, and necrosis. These features reflect the malignant potential of the tumor in terms of invasion and growth rate. Tumors without any of these features are grade I, and those with one of these features (usually atypia) are grade II. Tumors with 2 criteria and tumors with 3 or 4 criteria are WHO grades III and IV, respectively. Thus, the low-grade group of astrocytomas are grades I and II. According to the WHO data the lowest grade astrocytomas (grade I) make up only 2% of recorded astrocytomas, grade II 8%, and the higher grade anaplastic astrocytomas (grade III) 20%. The highest graded astrocytoma (grade IV GBM) is the most common primary nervous system cancer and second most frequent brain tumor after brain metastasis. Despite the low incidence of astrocytomas compared to other human cancers, mortality is significant, as the higher grades (III & IV) present high mortality rates (mainly due to late detection of the neoplasm).